REGENERX BIOPHARMACEUTICALS INC Quarterly Return On Equity in % from Q1 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Return On Equity for the quarter ending March 31, 2023 was 51.2 %, a 35.9% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Return On Equity for 2022 was 57.5 %, a 21.1% decline from 2021.
  • Regenerx Biopharmaceuticals Inc annual Return On Equity for 2021 was 72.9 %, a 31.1% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Return On Equity for 2020 was 55.6 %, a 19.9% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 51.2 -28.7 -35.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 57.5 -15.3 -21.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 66.2 +1.42 +2.19% Jul 1, 2022 Sep 30, 2022
Q2 2022 77.7 +23.5 +43.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 79.9 +27.9 +53.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 72.9 +17.3 +31.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 64.8 +7.33 +12.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 54.2 -9 -14.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 52.1 -16 -23.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 55.6 -13.8 -19.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 57.4 -8.79 -13.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 63.2 -5.49 -8% Apr 1, 2020 Jun 30, 2020
Q1 2020 68.1 +4.46 +7.01% Jan 1, 2020 Mar 31, 2020
Q4 2019 69.4 -25.3 -26.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 66.2 +54.1 +447% Jul 1, 2019 Sep 30, 2019
Q2 2019 68.6 +32.6 +90.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 63.6 +45.4 +250% Jan 1, 2019 Mar 31, 2019
Q4 2018 94.7 +100 Oct 1, 2018 Dec 31, 2018
Q3 2018 12.1 +0.13 +1.09% Jul 1, 2018 Sep 30, 2018
Q2 2018 36.1 +61.1 Apr 1, 2018 Jun 30, 2018
Q1 2018 18.2 +75.4 Jan 1, 2018 Mar 31, 2018
Q4 2017 -5.27 -2.22 -72.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 12 +0.85 +7.65% Jul 1, 2017 Sep 30, 2017
Q2 2017 -25 -62.5 -166% Apr 1, 2017 Jun 30, 2017
Q1 2017 -57.3 -157 -158% Jan 1, 2017 Mar 31, 2017
Q4 2016 -3.05 -102 -103% Oct 1, 2016 Dec 31, 2016
Q3 2016 11.1 -115 -91.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 37.6 -99.4 -72.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 99.5 -8.76 -8.09% Jan 1, 2016 Mar 31, 2016
Q4 2015 98.9 -49.3 -33.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 126 +4.88 +4.02% Jul 1, 2015 Sep 30, 2015
Q2 2015 137 +10.5 +8.34% Apr 1, 2015 Jun 30, 2015
Q1 2015 108 -33.5 -23.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 148 +104 +238% Oct 1, 2014 Dec 31, 2014
Q3 2014 121 +66.4 +121% Jul 1, 2014 Sep 30, 2014
Q2 2014 126 +64.4 +104% Apr 1, 2014 Jun 30, 2014
Q1 2014 142 +70.9 +100% Jan 1, 2014 Mar 31, 2014
Q4 2013 43.8 -47.7 -52.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 55 -152 -73.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 62 -663 -91.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 70.8 +2.08K Jan 1, 2013 Mar 31, 2013
Q4 2012 91.5 Oct 1, 2012 Dec 31, 2012
Q3 2012 207 Jul 1, 2012 Sep 30, 2012
Q2 2012 725 Apr 1, 2012 Jun 30, 2012
Q1 2012 -2.01K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.